• FirefoxInstall the new Firefox »
  •  Dow Up0.86% Nasdaq Up0.90%

    More On HEMA

    HemaCare Corp. (HEMA)

    -Other OTC
    0.17 0.00(0.00%) Feb 24
    Add to Portfolio
    ProfileGet Profile for:
    HemaCare Corp.
    15350 Sherman Way
    Suite 350
    Van Nuys, CA 91406
    United States - Map
    Phone: 877-310-0717
    Fax: 818-251-5300
    Website: http://www.hemacare.com

    Index Membership:N/A
    Industry:Specialized Health Services
    Full Time Employees:N/A

    Business Summary 

    HemaCare Corporation, together with its subsidiaries, provides biological blood products and services in the United States. The company operates through two segments, Blood Products and Therapeutic Services. The Blood Products segment provides apheresis platelets to The American National Red Cross; and offers apheresis products, human blood cells, cells and blood components, and apheresis collection services. It operates two platelet and one research product donor centers in California. This segment also specializes in the customized collection of human-derived biological products and services in accordance with organizations' research protocols. The Therapeutic Services segment offers therapeutic apheresis procedures, stem cell collection, and other blood treatments to patients with various disorders under contract with hospitals. The company also provides consulting and practice management services to hospitals, medical facilities, biotechnology companies, research organizations, and academic institutions. HemaCare Corporation primarily serves research, cellular therapy, health, and biotech related organizations, as well as healthcare providers and hospitals. The company was founded in 1978 and is headquartered in Van Nuys, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on HemaCare Corp.

    Key Executives 
    Mr. Peter C. van der Wal , 58
    Chief Exec. Officer, Pres and Director
    Ms. Maria Pia Muniz ,
    VP of Operations
    Mr. Lou Juliano R.Ph. ,
    Sr. VP of Research Products and Cell Therapy
    Dr. David Ciavarella M.D.,
    Medical Director of Coral Blood Services
    Dr. Melanie Osby M.D.,
    National Medical Director
    Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders